$SSOK
Sunstock, Inc.

2023 Q3 Form 10-Q Financial Statement

#000149315223028179 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $3.003M $3.158M $3.271M
YoY Change -8.63% -3.44% 5.01%
Cost Of Revenue $2.972M $3.124M $3.201M
YoY Change -8.75% -2.41% 4.0%
Gross Profit $31.55K $34.19K $69.85K
YoY Change 3.74% -51.05% 89.31%
Gross Profit Margin 1.05% 1.08% 2.14%
Selling, General & Admin $15.35K $20.23K $53.70K
YoY Change 18.26% -62.33% -42.8%
% of Gross Profit 48.65% 59.17% 76.88%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $55.00 $55.00 $240.00
YoY Change -73.93% -77.08% -67.21%
% of Gross Profit 0.17% 0.16% 0.34%
Operating Expenses $100.1K $28.46K $62.87K
YoY Change 377.82% -54.73% -40.68%
Operating Profit -$68.57K $5.728K $6.980K
YoY Change -825.11% -17.94% -110.1%
Interest Expense -$23.16K -$42.64K $1.443K
YoY Change -1704.99% -3054.95% 0.0%
% of Operating Profit -744.41% 20.67%
Other Income/Expense, Net -$23.16K -$166.2K -$101.5K
YoY Change -66.37% 63.73% -74.5%
Pretax Income -$91.73K -$160.5K -$94.56K
YoY Change 54.43% 69.75% -79.76%
Income Tax
% Of Pretax Income
Net Earnings -$91.73K -$160.5K -$94.56K
YoY Change 54.43% 69.75% -79.76%
Net Earnings / Revenue -3.05% -5.08% -2.89%
Basic Earnings Per Share -$0.02 -$0.03 -$0.02
Diluted Earnings Per Share -$0.02 -$0.03 -$22.92K
COMMON SHARES
Basic Shares Outstanding 5.022M shares 4.816M shares 4.126M shares
Diluted Shares Outstanding 5.022M shares 4.836M shares 4.126M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.08K $9.880K $28.73K
YoY Change -45.46% -65.61% -17.3%
Cash & Equivalents $18.08K $9.884K $28.73K
Short-Term Investments
Other Short-Term Assets $15.37K $17.75K $5.490K
YoY Change 193.32% 223.32% 9.8%
Inventory $1.795M $1.798M $1.456M
Prepaid Expenses $15.37K $17.75K $5.492K
Receivables
Other Receivables
Total Short-Term Assets $1.829M $1.826M $1.490M
YoY Change 23.78% 22.51% 29.11%
LONG-TERM ASSETS
Property, Plant & Equipment $258.00 $313.00 $691.00
YoY Change -46.14% -54.7% -98.01%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.683K $3.164K $19.46K
YoY Change -89.17% -83.74% -43.84%
TOTAL ASSETS
Total Short-Term Assets $1.829M $1.826M $1.490M
Total Long-Term Assets $1.683K $3.164K $19.46K
Total Assets $1.831M $1.829M $1.510M
YoY Change 22.61% 21.14% 26.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $531.5K $450.3K $523.8K
YoY Change 10.26% -14.04% 3737.58%
Deferred Revenue
YoY Change
Short-Term Debt $12.20K $0.00 $273.4K
YoY Change -96.62% -100.0% 3750.7%
Long-Term Debt Due $7.530K $6.690K $3.430K
YoY Change 137.54% 95.04%
Total Short-Term Liabilities $587.5K $493.3K $837.0K
YoY Change -33.41% -41.06% 133.77%
LONG-TERM LIABILITIES
Long-Term Debt $142.5K $143.3K $146.6K
YoY Change -2.97% -2.22% -18.69%
Other Long-Term Liabilities $2.850K
YoY Change -84.82%
Total Long-Term Liabilities $142.5K $143.3K $149.4K
YoY Change -2.97% -4.09% -24.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $587.5K $493.3K $837.0K
Total Long-Term Liabilities $142.5K $143.3K $149.4K
Total Liabilities $730.0K $636.6K $986.4K
YoY Change -29.07% -35.46% 77.07%
SHAREHOLDERS EQUITY
Retained Earnings -$66.18M -$66.09M -$62.26M
YoY Change 6.2% 6.16%
Common Stock $502.00 $502.00 $412.00
YoY Change 21.84% 21.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.101M $1.192M $523.2K
YoY Change
Total Liabilities & Shareholders Equity $1.831M $1.829M $1.510M
YoY Change 22.61% 21.14% 26.98%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$91.73K -$160.5K -$94.56K
YoY Change 54.43% 69.75% -79.76%
Depreciation, Depletion And Amortization $55.00 $55.00 $240.00
YoY Change -73.93% -77.08% -67.21%
Cash From Operating Activities -$4.010K -$29.74K -$71.69K
YoY Change -95.17% -58.52% -27.16%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.21K 34.98K 63.00K
YoY Change -86.03% -44.48% -13.49%
NET CHANGE
Cash From Operating Activities -4.010K -29.74K -71.69K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 12.21K 34.98K 63.00K
Net Change In Cash 8.200K 5.240K -8.690K
YoY Change 85.52% -160.3% -66.05%
FREE CASH FLOW
Cash From Operating Activities -$4.010K -$29.74K -$71.69K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001559157
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022Q2 SSOK Loss From Settlement Of Debt With Related Party
LossFromSettlementOfDebtWithRelatedParty
usd
SSOK Loss From Settlement Of Debt With Related Party
LossFromSettlementOfDebtWithRelatedParty
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
SSOK Loss From Settlement Of Debt With Related Party
LossFromSettlementOfDebtWithRelatedParty
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
SSOK Noncash Extinguishment Of Debt
NoncashExtinguishmentOfDebt
usd
us-gaap Stock Issued1
StockIssued1
usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54830
dei Entity Registrant Name
EntityRegistrantName
SUNSTOCK, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-1856372
dei Entity Address Address Line1
EntityAddressAddressLine1
111 Vista Creek Circle
dei Entity Address City Or Town
EntityAddressCityOrTown
Sacramento
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95835
dei City Area Code
CityAreaCode
916
dei Local Phone Number
LocalPhoneNumber
860-9622
dei Security12b Title
Security12bTitle
Common Stock.
dei Trading Symbol
TradingSymbol
SSOK
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5021857 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9884 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16691 usd
CY2023Q2 SSOK Inventory Coins Current
InventoryCoinsCurrent
1022996 usd
CY2022Q4 SSOK Inventory Coins Current
InventoryCoinsCurrent
950637 usd
CY2023Q2 SSOK Inventory Precious Metals Current
InventoryPreciousMetalsCurrent
775046 usd
CY2022Q4 SSOK Inventory Precious Metals Current
InventoryPreciousMetalsCurrent
801022 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
17752 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5155 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
1825678 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1773505 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
313 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
424 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2851 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11114 usd
CY2023Q2 us-gaap Assets
Assets
1828842 usd
CY2022Q4 us-gaap Assets
Assets
1785043 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
483755 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
480137 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2851 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11114 usd
CY2023Q2 us-gaap Debt Current
DebtCurrent
6692 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
5047 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
493298 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
502298 usd
CY2023Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
143308 usd
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
144953 usd
CY2023Q2 us-gaap Liabilities
Liabilities
636606 usd
CY2022Q4 us-gaap Liabilities
Liabilities
647251 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5021857 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5021857 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4815857 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4815857 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
502 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
481 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
67279869 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
67053289 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66088135 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65915978 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1192236 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1137792 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1828842 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1785043 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3158247 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3270927 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6498131 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6519910 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
3124057 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
3201080 usd
us-gaap Cost Of Revenue
CostOfRevenue
6417450 usd
us-gaap Cost Of Revenue
CostOfRevenue
6376447 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
34190 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
69847 usd
us-gaap Gross Profit
GrossProfit
80681 usd
us-gaap Gross Profit
GrossProfit
143463 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
20229 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
53518 usd
us-gaap Professional Fees
ProfessionalFees
82281 usd
us-gaap Professional Fees
ProfessionalFees
86013 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
182 usd
us-gaap Share Based Compensation
ShareBasedCompensation
556 usd
CY2023Q2 us-gaap Other Expenses
OtherExpenses
8233 usd
CY2022Q2 us-gaap Other Expenses
OtherExpenses
9167 usd
us-gaap Other Expenses
OtherExpenses
16481 usd
us-gaap Other Expenses
OtherExpenses
18340 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
28462 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
62867 usd
us-gaap Operating Expenses
OperatingExpenses
98762 usd
us-gaap Operating Expenses
OperatingExpenses
104909 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
5728 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
6980 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-18081 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
38554 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-40051 usd
CY2022Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-96253 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-25976 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-50996 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
30250 usd
CY2023Q2 SSOK Loss From Settlement Of Debt With Related Party
LossFromSettlementOfDebtWithRelatedParty
123600 usd
SSOK Loss From Settlement Of Debt With Related Party
LossFromSettlementOfDebtWithRelatedParty
123600 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-166239 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-101535 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-154076 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30216 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-160511 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-94555 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-172157 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8338 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-160511 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-94555 usd
us-gaap Net Income Loss
NetIncomeLoss
-172157 usd
us-gaap Net Income Loss
NetIncomeLoss
8338 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4836231 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4836231 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4126387 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4126387 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4826100 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4826100 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4126387 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4126387 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
514911 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
102893 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
617804 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-94555 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
523249 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1137792 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-11646 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1126146 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1126146 usd
CY2023Q2 SSOK Stock Issued During Period Valuefor Related Party Notes Payable
StockIssuedDuringPeriodValueforRelatedPartyNotesPayable
226601 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-160511 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-160511 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1192236 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1192236 usd
us-gaap Net Income Loss
NetIncomeLoss
-172157 usd
us-gaap Net Income Loss
NetIncomeLoss
8338 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-25976 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-50996 usd
us-gaap Depreciation
Depreciation
111 usd
us-gaap Depreciation
Depreciation
594 usd
SSOK Loss From Settlement Of Debt With Related Party
LossFromSettlementOfDebtWithRelatedParty
123600 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
30250 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
72359 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
114302 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
12597 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-163 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9139 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-37274 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-98287 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-121735 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
91480 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
120300 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
91480 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
120300 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6807 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1435 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16691 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30168 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9884 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
28733 usd
SSOK Noncash Extinguishment Of Debt
NoncashExtinguishmentOfDebt
30250 usd
us-gaap Stock Issued1
StockIssued1
103000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_zkUF9vCL9l17" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_ztyYSWBMKFVb">USE OF ESTIMATES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed and consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made by the Company’s management include realizability and valuation of inventories and value of stock-based transactions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_z1Gmx1nXnWw7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_z83NxTaFNm86">CONCENTRATION OF RISK</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high quality banking institutions. The Company did not have cash balances in excess of the Federal Deposit Insurance Corporation limit as of June 30, 2023 and December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-40051 usd
CY2022Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-96253 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-25976 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-50996 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2022Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66088135 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
58460 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
58460 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58147 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58036 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
313 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
424 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
55 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
240 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
111 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
594 usd
CY2023Q2 SSOK Accrued Court Decision Current
AccruedCourtDecisionCurrent
260308 usd
CY2022Q4 SSOK Accrued Court Decision Current
AccruedCourtDecisionCurrent
260308 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
133000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
131500 usd
CY2023Q2 SSOK Accrued Audit Fees Current
AccruedAuditFeesCurrent
14894 usd
CY2022Q4 SSOK Accrued Audit Fees Current
AccruedAuditFeesCurrent
8089 usd
CY2023Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
36326 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
36326 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4631 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
17322 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
14436 usd
CY2023Q2 SSOK Accrued Interest Payable Related Party
AccruedInterestPayableRelatedParty
12270 usd
CY2022Q4 SSOK Accrued Interest Payable Related Party
AccruedInterestPayableRelatedParty
16176 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9635 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8671 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
483755 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
480137 usd
CY2023Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
36326 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
14155 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
8940 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
8940 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
8940 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
8940 usd
CY2023Q2 SSOK Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
200405 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
250320 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
100320 usd
CY2023Q2 us-gaap Loans Payable
LoansPayable
150000 usd
CY2023Q2 us-gaap Loans Payable Current
LoansPayableCurrent
6692 usd
CY2023Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
143308 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P26Y10M24D
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q2 us-gaap Shares Issued
SharesIssued
0 shares

Files In Submission

Name View Source Status
0001493152-23-028179-index-headers.html Edgar Link pending
0001493152-23-028179-index.html Edgar Link pending
0001493152-23-028179.txt Edgar Link pending
0001493152-23-028179-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ssok-20230630.xsd Edgar Link pending
ssok-20230630_lab.xml Edgar Link unprocessable
ssok-20230630_def.xml Edgar Link unprocessable
ssok-20230630_cal.xml Edgar Link unprocessable
ssok-20230630_pre.xml Edgar Link unprocessable